Leerink Partnrs Issues Pessimistic Forecast for THC Earnings

Tenet Healthcare Co. (NYSE:THC - Free Report) - Stock analysts at Leerink Partnrs dropped their Q1 2025 EPS estimates for Tenet Healthcare in a note issued to investors on Wednesday, February 12th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn $3.07 per share for the quarter, down from their prior estimate of $3.57. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Leerink Partnrs also issued estimates for Tenet Healthcare's Q1 2025 earnings at $3.07 EPS, Q3 2025 earnings at $2.71 EPS, Q3 2025 earnings at $2.71 EPS, FY2025 earnings at $11.82 EPS, FY2025 earnings at $11.82 EPS, FY2026 earnings at $13.64 EPS, FY2026 earnings at $13.64 EPS, FY2027 earnings at $15.90 EPS and FY2027 earnings at $15.90 EPS.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.

Several other research analysts have also recently weighed in on THC. Wells Fargo & Company cut Tenet Healthcare from an "overweight" rating to an "equal weight" rating and decreased their price target for the stock from $205.00 to $150.00 in a research note on Monday, November 25th. JPMorgan Chase & Co. reissued an "overweight" rating and set a $175.00 price target on shares of Tenet Healthcare in a report on Tuesday, December 17th. StockNews.com lowered shares of Tenet Healthcare from a "buy" rating to a "hold" rating in a research report on Thursday, February 13th. KeyCorp decreased their target price on shares of Tenet Healthcare from $200.00 to $185.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 7th. Finally, Raymond James downgraded shares of Tenet Healthcare from a "strong-buy" rating to an "outperform" rating and set a $195.00 target price for the company. in a report on Friday, November 22nd. Four investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $163.19.

Tenet Healthcare Stock Up 1.3 %

NYSE THC traded up $1.79 during mid-day trading on Monday, reaching $137.44. The stock had a trading volume of 1,854,202 shares, compared to its average volume of 1,328,000. The company has a fifty day moving average price of $133.00 and a 200 day moving average price of $147.87. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70. Tenet Healthcare has a 1 year low of $88.98 and a 1 year high of $171.20. The stock has a market cap of $13.07 billion, a PE ratio of 4.26, a price-to-earnings-growth ratio of 1.00 and a beta of 2.05.

Institutional Trading of Tenet Healthcare

Large investors have recently made changes to their positions in the business. FMR LLC raised its position in Tenet Healthcare by 88.0% during the third quarter. FMR LLC now owns 7,700,693 shares of the company's stock valued at $1,279,855,000 after purchasing an additional 3,604,161 shares during the period. Norges Bank purchased a new stake in Tenet Healthcare in the 4th quarter worth about $190,819,000. Wealthfront Advisers LLC purchased a new position in shares of Tenet Healthcare during the fourth quarter valued at approximately $69,059,000. Geode Capital Management LLC raised its holdings in shares of Tenet Healthcare by 23.6% in the third quarter. Geode Capital Management LLC now owns 2,044,667 shares of the company's stock worth $339,893,000 after buying an additional 390,316 shares during the period. Finally, Raymond James Financial Inc. bought a new stake in shares of Tenet Healthcare during the 4th quarter worth approximately $49,001,000. 95.44% of the stock is currently owned by institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.